Sengun IS - Search Results

1

PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients.

Kim SH, Henkel JS, Beers DR, Sengun IS, Simpson EP, Goodman JC, Engelhardt JI, Siklós L, Appel SH. Kim SH, et al. Among authors: sengun is. J Neuropathol Exp Neurol. 2003 Jan;62(1):88-103. doi: 10.1093/jnen/62.1.88. J Neuropathol Exp Neurol. 2003. PMID: 12528821

2

Serum anti-Fas antibody levels in amyotrophic lateral sclerosis.

Sengun IS, Appel SH. Sengun IS, et al. J Neuroimmunol. 2003 Sep;142(1-2):137-40. doi: 10.1016/s0165-5728(03)00263-7. J Neuroimmunol. 2003. PMID: 14512172

3

Importance of diaphragm thickness in amyotrophic lateral sclerosis patients with diaphragm pacing system implantation.

Sanli A, Sengun IS, Tertemiz KC, Alpaydin AO, Karacam V, Sanli BA, Oz D, Ozalevli S, Ozdemir N. Sanli A, et al. Among authors: sengun is. Surg Endosc. 2016 Jan;30(1):154-8. doi: 10.1007/s00464-015-4175-0. Epub 2015 Mar 25. Surg Endosc. 2016. PMID: 25805242

4

Multiple sclerosis and parkinsonism: a case report.

Ozturk V, Idiman E, Sengun IS, Yuksel Z. Ozturk V, et al. Among authors: sengun is. Funct Neurol. 2002 Jul-Sep;17(3):145-7. Funct Neurol. 2002. PMID: 12549720

5

Preoperative parameters and their prognostic value in amyotrophic lateral sclerosis patients undergoing implantation of a diaphragm pacing stimulation system.

Şanlı A, Şengün IŞ, Karaçam V, Alpaydın AÖ, Tertemiz KC, Özalevli S, Şanlı BA, Kaya A, Özdemir N. Şanlı A, et al. Among authors: sengun is. Ann Indian Acad Neurol. 2017 Jan-Mar;20(1):51-54. doi: 10.4103/0972-2327.192388. Ann Indian Acad Neurol. 2017. PMID: 28298842 Free PMC article.

6

Vestibular impairment in Charcot-Marie-Tooth disease.

Akdal G, Koçoğlu K, Tanrıverdizade T, Bora E, Bademkıran F, Yüceyar AN, Ekmekçi Ö, Şengün İŞ, Karasoy H. Akdal G, et al. Among authors: sengun is. J Neurol. 2021 Feb;268(2):526-531. doi: 10.1007/s00415-020-10186-x. Epub 2020 Aug 30. J Neurol. 2021. PMID: 32862243

7

'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.

Vissing J, Jacob S, Fujita KP, O'Brien F, Howard JF; REGAIN study group. Vissing J, et al. J Neurol. 2020 Jul;267(7):1991-2001. doi: 10.1007/s00415-020-09770-y. Epub 2020 Mar 18. J Neurol. 2020. PMID: 32189108 Free PMC article. Clinical Trial.

8

Vestibular impairment in chronic inflammatory demyelinating polyneuropathy.

Akdal G, Tanrıverdizade T, Şengün İ, Bademkıran F, Koçoğlu K, Yüceyar AN, Ekmekçi Ö, Karasoy H, Halmágyi GM. Akdal G, et al. J Neurol. 2018 Feb;265(2):381-387. doi: 10.1007/s00415-017-8712-8. Epub 2017 Dec 19. J Neurol. 2018. PMID: 29260355

9

Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.

Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ; PREVENT Study Group. Wingerchuk DM, et al. Ann Neurol. 2021 Jun;89(6):1088-1098. doi: 10.1002/ana.26049. Epub 2021 Feb 27. Ann Neurol. 2021. PMID: 33586143 Free PMC article. Clinical Trial.

10

A database for screening and registering late onset Pompe disease in Turkey.

Gokyigit MC, Ekmekci H, Durmus H, Karlı N, Koseoglu E, Aysal F, Kotan D, Ali A, Koytak PK, Karasoy H, Yaman A, Sengun İS, Sayin R, Tiftikcioglu BI, Soysal A, Tutkavul K, Bayrak AO, Kısabay A, Elci MA, Yayla V, Yılmaz İA, Ozdamar SE, Erdogan C, Tasdemir N, Serdaroglu Oflazer P; Turkish Study Group for Late Onset Pompe Disease. Gokyigit MC, et al. Among authors: sengun is. Neuromuscul Disord. 2018 Mar;28(3):262-267. doi: 10.1016/j.nmd.2017.12.008. Epub 2017 Dec 20. Neuromuscul Disord. 2018. PMID: 29395671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page